A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Public ClinicalTrials.gov record NCT00528879. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Combination With Metformin in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical research study is to learn whether dapagliflozin can help reduce blood sugar levels in participants with Type 2 diabetes that is not well controlled on metformin alone. The safety of this treatment will also be studied.
Study identification
- NCT ID
- NCT00528879
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 915 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 77 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2007 (Type not available)
- Primary completion
- Nov 2008 (Actual)
- Completion
- May 2010 (Actual)
- Last update posted
- Oct 20, 2015
2007 – 2010
United States locations
- U.S. sites
- 28
- U.S. states
- 15
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Advantage / Desert Clinical Res, Llc | Tempe | Arizona | 85282 | — |
| Medical Group Of Encino | Encino | California | 91436 | — |
| Valley Research | Fresno | California | 93720 | — |
| Randall Shue, D.O. | Los Angeles | California | 90023 | — |
| Diabetes Medical Center Of California | Northridge | California | 91325 | — |
| Ritchken & First M.D.'S | San Diego | California | 92117 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| Raikhel, Marina | Torrance | California | 90505 | — |
| Express Care Clinical Res | Colorado Springs | Colorado | 80909 | — |
| Denver Internal Medicine | Denver | Colorado | 80209 | — |
| New West Physicians | Golden | Colorado | 80401 | — |
| Central Florida Clinical Trials, Inc. | Altamonte Springs | Florida | 32701 | — |
| Family Care Associates Of Nw Florida | Chipley | Florida | 32428 | — |
| Health Partners Research Foundation | Minneapolis | Minnesota | 56440 | — |
| Woodlake Research | Chesterfield | Missouri | 63017 | — |
| Nevada Alliance Against Diabetes | Las Vegas | Nevada | 89101 | — |
| Diabetes & Endocrinology Consultants, Pc | Morehead City | North Carolina | 28557 | — |
| Newark Physician Associates | Newark | Ohio | 43055 | — |
| Integris Family Care S. Penn | Oklahoma City | Oklahoma | 73159 | — |
| Cumberland Valley Endocrinology Center, Llc | Carlisle | Pennsylvania | 17013 | — |
| Banksville Medical Pc | Pittsburgh | Pennsylvania | 15216 | — |
| Palmetto Clinical Research | Summerville | South Carolina | 29485 | — |
| Southeastern Research Assoc | Taylors | South Carolina | 29687 | — |
| Texas Center For Drug Development, P.A. | Houston | Texas | 77081 | — |
| Diabetes & Glandular Disease Research Associates, Inc. | San Antonio | Texas | 78229 | — |
| S.A.M. Clinical Research Center | San Antonio | Texas | 78229 | — |
| Optimum Clinical Research | Salt Lake City | Utah | 84102 | — |
| Office Of Dr. Gray | Spokane | Washington | 99216 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00528879, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2015 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00528879 live on ClinicalTrials.gov.